BioXcel Therapeutics, Inc.

NASDAQ:BTAI

0.3511 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Operating Activities:
Net Income -13.65-8.299-26.791-22.256-50.486-53.515-52.796-54.808-41.807-37.67-31.472-26.125-26.811-27.619-26.376-21.086-24.753-21.419-14.911-8.275-9.018-8.471-7.204-7.075-4.887-3.026-4.282-2.528-0.917-0.565-0.529
Depreciation & Amortization 0.0770.0770.0780.0780.0790.0810.080.0810.0850.0840.0770.0760.0770.0790.0650.0450.0480.0480.047-0.0620.0960.0850.0370.0080.0070.002000.001-0.0010.001
Deferred Income Tax 000-15.3810.001-0.546000003.881000-1.02000-2.39000-2.6620000000
Stock Based Compensation 1.8651.0573.4333.5994.0146.1244.8774.5474.4834.4823.8252.2364.8856.7695.5656.6115.2681.9560.7760.6540.7761.030.6820.1330.8890.7411.3191.090.3160.0930.107
Change In Working Capital -1.323-5.4214.27-9.28.0198.889-5.47610.3415.496-0.32-4.8433.8811.604-1.6111.106-5.8420.3364.5951.931-0.2410.4871.8290.3152.5930.805-2.6871.9510.340.2780.128-0.01
Accounts Receivables 0.8090-0.3070.664-0.304-0.148-0.035-000000000000000000000000
Change In Inventory 1.1550-0.4480.027-0.0930.0270.033-0.577-0.013-0.713-0.68200000000000000000000
Change In Accounts Payables -1.661-4.1624.826-12.3177.2556.497-4.6549.2350.483.991-0.6762.0432.2480.1560.403-4.6750.0453.8943.7690.3310.0961.551.6032.6170.654-2.8132.7430.3320.2890.127-0.011
Other Working Capital -1.626-1.2590.1992.4261.1612.5134.6561.6835.029-3.598-3.4851.838-0.644-1.7670.703-1.1670.2910.701-1.838-0.5720.3910.279-1.288-0.0240.1510.126-0.7920.008-0.0110.0010.001
Other Non Cash Items -3.307-10.5880.82216.2970.7890.7610.9621.20.5570.3215.337-3.8810.0466.9285.6951.020.1673.8943.7692.390.269-0.50.52.6620.653-2.81410.3320.2890.127-0.011
Operating Cash Flow -16.338-23.174-17.706-26.863-37.584-38.206-52.353-38.639-31.186-33.103-32.413-19.932-20.199-22.382-19.64-20.272-19.101-14.82-12.157-7.924-7.659-6.027-5.67-4.341-3.186-4.97-1.012-1.098-0.322-0.345-0.431
Investing Activities:
Investments In Property Plant And Equipment 00000-0.020-00-0.019-0.12-0.012-0.017-0.1-0.316-0.270.005-0.035-0.016-0.002-0.043-0.225-0.6-0.158-0.062-0.1200000
Acquisitions Net 0000000000000000000000000000000
Purchases Of Investments 0000000000000000000000000000000
Sales Maturities Of Investments 0000000000000000000000000000000
Other Investing Activites 0000000000000000000-0.87000-0.340000000
Investing Cash Flow 00000-0.020-00-0.019-0.12-0.012-0.017-0.1-0.316-0.270.005-0.035-0.016-0.002-0.043-0.225-0.6-0.158-0.062-0.1200000
Financing Activities:
Debt Repayment 000000003000000000000000000-0.371-0.0190.1720.2850
Common Stock Issued 0.4685.47626.7432.37500.2524.65700.0480.18500-0.034101.0270.852-0.034187.008068.8110.07417.5060.2300.0010056.5121.310.75100
Common Stock Repurchased 000000000000000000-9.0240000000000-0.2170
Dividends Paid 0000000000000000000000000000000
Other Financing Activities -0.014-0.172-0.117-0.25200.25-0.5080.050.04866.139000.1050.4970.8520.2670.0210.2710.0390.0260.483-0.3090.001-0.0590.021-0.026-0.551-0.06-0.1320.3450.431
Financing Cash Flow 0.4545.30426.6262.12300.2524.1490.0530.04866.139000.071101.5240.8520.233187.0290.27159.8260.117.989-0.0790.001-0.0580.021-0.02655.591.2310.7910.630.431
Other Information:
Effect Of Forex Changes On Cash 0000000000000000000000000000000
Net Change In Cash -15.884-17.878.92-24.74-37.584-37.976-28.204-38.589-1.13833.017-32.533-19.944-20.14579.042-19.104-20.309167.933-14.58447.653-7.82610.287-6.331-6.269-4.557-3.227-5.11654.5780.1330.4690.2850
Cash At End Of Period 40.38756.27174.14165.22189.961127.545165.521193.725232.314233.452200.435232.968252.912273.057194.015213.119233.42865.49580.07932.42640.25229.96536.29642.56547.12250.34955.4650.8870.7540.2850